Detalhe da pesquisa
1.
Navigating a newly diagnosed cancer through clinician-facilitated discussions of health-related patient values: a qualitative analysis.
BMC Palliat Care
; 21(1): 29, 2022 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35249532
2.
Blood and Marrow Transplant Clinical Trials Network Study 1102 heralds a new era in hematopoietic cell transplantation in high-risk myelodysplastic syndromes: Challenges and opportunities in implementation.
Cancer
; 127(23): 4339-4347, 2021 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34375439
3.
Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 15(1): 60-87, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28040720
4.
Therapy-related myeloid neoplasms: what's in a name?
Curr Opin Hematol
; 23(2): 161-6, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26779614
5.
Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study.
Lancet Oncol
; 16(9): 1025-1036, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26234174
6.
Progression of RAS-mutant leukemia during RAF inhibitor treatment.
N Engl J Med
; 367(24): 2316-21, 2012 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-23134356
7.
Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study.
Cancer Immunol Immunother
; 64(2): 237-47, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25351719
8.
Recent advances in the management of therapy-related myelodysplastic syndromes and acute myeloid leukemia.
Curr Opin Hematol
; 20(2): 137-43, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23343830
9.
Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia.
Haematologica
; 98(6): 908-12, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23349305
10.
Phase 3 results for vosaroxin/cytarabine in the subset of patients ≥60 years old with refractory/early relapsed acute myeloid leukemia.
Haematologica
; 103(11): e514-e518, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29794146
11.
Translocation t(11;17) in de novo myelodysplastic syndrome not associated with acute myeloid or acute promyelocytic leukemia.
Acta Haematol
; 129(1): 48-54, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23147462
12.
Molecular International Prognostic Scoring System for Myelodysplastic Syndromes.
NEJM Evid
; 1(7): EVIDoa2200008, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38319256
13.
Mutational correlates of response to hypomethylating agent therapy in acute myeloid leukemia.
Haematologica
; 101(11): e457-e460, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27418649
14.
Palliative Medicine in Myelodysplastic Syndromes: Patients and Caregivers - A Qualitative Study.
BMJ Support Palliat Care
; 2021 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33903261
15.
TP53 Combined Phenotype Score Is Associated with the Clinical Outcome of TP53-Mutated Myelodysplastic Syndromes.
Cancers (Basel)
; 13(21)2021 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34771665
16.
Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms.
Leukemia
; 35(12): 3542-3550, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34172893
17.
Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: a single-centre, single-arm, phase 2 trial.
Lancet Haematol
; 7(8): e566-e574, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32735836
18.
Cancer therapy shapes the fitness landscape of clonal hematopoiesis.
Nat Genet
; 52(11): 1219-1226, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33106634
19.
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.
Nat Med
; 26(10): 1549-1556, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32747829
20.
Tolerability, pharmacodynamics, and pharmacokinetics studies of depsipeptide (romidepsin) in patients with acute myelogenous leukemia or advanced myelodysplastic syndromes.
Clin Cancer Res
; 14(3): 826-32, 2008 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18245545